Scott Gottlieb, MD 🇺🇸 (@ScottGottliebMD) / X

Scott Gottlieb, MD 🇺🇸

23.1K posts

Scott Gottlieb, MD 🇺🇸

@ScottGottliebMD

Senior Fellow @AEI. Partner @NEA. Contributor @CNBC. 23rd Commissioner of the @US_FDA. Public Boards: @Pfizer @Illumina @TempusAI @UnitedHealthGrp

Washington, DC

uncontrolledspread.com

Joined May 2009

Scott Gottlieb, MD 🇺🇸
@ScottGottliebMD
11h
1/2 This is a large number of cases over a short period, and the count may still rise. It's at least the 2nd major outbreak this year linked to produce from a distinct Mexican growing region—jalapeños from Sinaloa after iceberg lettuce from central Mexico
Chipotle, Qdoba remove jalapeños tied to salmonella outbreak that has spread to 27 states
From washingtonpost.com
Scott Gottlieb, MD 🇺🇸
@ScottGottliebMD
Jul 26
FDA has done an effective job tracing much of this outbreak back to growing regions in central Mexico and specific farms. There are steps consumers can take to further mitigate risk. Retailers and restaurants with good supply chain management have shifted their purchasing. People
Cyclospora outbreak has many changing eating habits, CBS News poll finds; mixed and partisan...
From cbsnews.com
Scott Gottlieb, MD 🇺🇸
@ScottGottliebMD
Jul 21
My segment on @SquawkCNBC on cyclospora in bagged lettuce and FDA’s effort to trace cases to a grower in Mexico and isolate the root cause of the outbreak. Discussed steps consumers can take. FDA’s ongoing oversight should mitigate risks. @AEI
Scott Gottlieb, MD 🇺🇸
@ScottGottliebMD
Jul 20
📝FDA seems to have relied on a strong epidemiological case here: Michigan’s ingredient-level analysis had 90% of interviewed cases eating iceberg lettuce. FDA’s traceback then quickly converged on a single supplier, all things considered. Strong supply chain records at a single
U.S. FDA
@US_FDA
Jul 20
To clarify, this false-positive lab sample DOES NOT change the basis for FDA’s ongoing outbreak investigation or the overwhelming epidemiological data supporting the current voluntary recall by Taylor Farms. Over the weekend, FDA alerted Taylor Farms that a new sample of
Scott Gottlieb, MD 🇺🇸
@ScottGottliebMD
Jun 22
👏👏 US has an inherent advantage in conducting proof-of-concept studies, because good medical care, to support patients receiving complex therapies, is key and US does that best But the time and cost advantage can’t tilt so heavily against US-based trials or we’ll lose our edge
The Wall Street Journal
@WSJ
Jun 22
FDA, NIH officials unveil package of regulatory tweaks as more companies go elsewhere for drug research. on.wsj.com/4oG08Vv